Economic burden of childhood autism spectrum disorders TA Lavelle, MC Weinstein, JP Newhouse, K Munir, KA Kuhlthau, ... Pediatrics 133 (3), e520-e529, 2014 | 672 | 2014 |
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of … DJ Cohen, A Bakhai, C Shi, L Githiora, T Lavelle, RH Berezin, MB Leon, ... Circulation 110 (5), 508-514, 2004 | 301 | 2004 |
Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry … MR Reynolds, T Lavelle, V Essebag, DJ Cohen, P Zimetbaum American heart journal 152 (6), 1097-1103, 2006 | 246 | 2006 |
Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary … DJ Cohen, AM Lincoff, TA Lavelle, HL Chen, A Bakhai, RH Berezin, ... Journal of the American College of Cardiology 44 (9), 1792-1800, 2004 | 144 | 2004 |
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial A Bakhai, GW Stone, E Mahoney, TA Lavelle, C Shi, RH Berezin, ... Journal of the American College of Cardiology 48 (2), 253-261, 2006 | 93 | 2006 |
Family and caregiver spillover effects in cost-utility analyses of Alzheimer’s disease interventions PJ Lin, B D’Cruz, AA Leech, PJ Neumann, M Sanon Aigbogun, ... Pharmacoeconomics 37, 597-608, 2019 | 70 | 2019 |
Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: one … DJ Cohen, TA Lavelle, B Van Hout, H Li, Y Lei, K Robertus, D Pinto, ... Catheterization and Cardiovascular Interventions 79 (2), 198-209, 2012 | 68 | 2012 |
Excluding patients from transplant due to social support: results from a national survey of transplant providers K Ladin, J Emerson, K Berry, Z Butt, EJ Gordon, N Daniels, TA Lavelle, ... American Journal of Transplantation 19 (1), 193-203, 2019 | 66 | 2019 |
Variation in the spillover effects of illness on parents, spouses, and children of the chronically ill TA Lavelle, E Wittenberg, K Lamarand, LA Prosser Applied health economics and health policy 12, 117-124, 2014 | 65 | 2014 |
Family spillover effects in pediatric cost-utility analyses TA Lavelle, BN D’Cruz, B Mohit, WJ Ungar, LA Prosser, K Tsiplova, ... Applied health economics and health policy 17, 163-174, 2019 | 61 | 2019 |
Costs and cost‐effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial EM Mahoney, D Greenberg, TA Lavelle, A Natarajan, R Berezin, KJ Ishak, ... Catheterization and Cardiovascular Interventions 77 (4), 463-472, 2011 | 56 | 2011 |
Cost-effectiveness of 2009 pandemic influenza A (H1N1) vaccination in the United States LA Prosser, TA Lavelle, AE Fiore, CB Bridges, C Reed, S Jain, ... Plos one 6 (7), e22308, 2011 | 54 | 2011 |
Health care costs and opioid use associated with high-impact chronic spinal pain in the United States PM Herman, N Broten, TA Lavelle, ME Sorbero, ID Coulter Spine 44 (16), 1154-1161, 2019 | 53 | 2019 |
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial DJ Cohen, SA Murphy, DS Baim, TA Lavelle, RH Berezin, DE Cutlip, ... Journal of the American College of Cardiology 44 (9), 1801-1808, 2004 | 52 | 2004 |
How important is social support in determining patients’ suitability for transplantation? Results from a National Survey of Transplant Clinicians K Ladin, J Emerson, Z Butt, EJ Gordon, DW Hanto, J Perloff, N Daniels, ... Journal of medical ethics 44 (10), 666-674, 2018 | 45 | 2018 |
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions TA Lavelle, X Feng, M Keisler, JT Cohen, PJ Neumann, D Prichard, ... Genetics in Medicine 24 (6), 1349-1361, 2022 | 43 | 2022 |
Autism: A global framework for action KM Munir, TA Lavelle, DT Helm, D Thompson, J Prestt, MW Azeem Report of the WISH Autism Forum, 2016 | 38 | 2016 |
Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza TA Lavelle, TM Uyeki, LA Prosser The Journal of pediatrics 160 (1), 67-73. e6, 2012 | 31 | 2012 |
Implementation of medical homes in federally qualified health centers JW Timbie, CM Setodji, A Kress, TA Lavelle, MW Friedberg, PJ Mendel, ... New England Journal of Medicine 377 (3), 246-256, 2017 | 30 | 2017 |
The cost-effectiveness of treatments for attention deficit-hyperactivity disorder and autism spectrum disorder in children and adolescents: a systematic review F Sampaio, I Feldman, TA Lavelle, N Skokauskas European Child & Adolescent Psychiatry 31 (11), 1655-1670, 2022 | 29 | 2022 |